3.3 Fat Metabolism While Hexarelin is not a metabolic peptide in the same class as Semaglutide or Tirzepatide, elevated GH/IGF-1 signaling drives: Increased lipolysis (fat breakdown) Enhanced fatty acid oxidation Reduction in visceral adipose tissue Tesamorelin, an FDA-approved GHRH analog, received approval specifically for visceral fat reduction demonstrating that GH-axis stimulation has meaningful metabolic effects
That changed when a very dedicated group of smart individuals got together to improve peoples lives by making an affordably priced GGC supplement commercially available
Assessment of insulin sensitivity/ resistance
While some individuals may feel liberated by reduced hunger, others may experience distress, alienation, or loss of enjoyment associated with food
To protect your patients health and your own liability, providers should have a clear, documented process they follow every time when deciding if a patient is a candidate for semaglutide drugs